Hepatobiliary Cancer: Clinical Trials

2 trials for Hepatobiliary Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 not yet recruiting. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Active not recruiting 1, Not yet recruiting 1
Phase 31Not yet recruiting 1

Follow Hepatobiliary Cancer: new trials by email Literature Review of Hepatobiliary Cancer trials Research Report on Hepatobiliary Cancer

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Impact of Comprehensive Geriatric Management on Morbidity and Quality of Life in Elderly Patients Undergoing Major Hepatectomy and Pancreaticoduodenectomy for Cancer
Comprehensive Geriatric Assessment - Hepatobiliary Cancer, Pancreatic Cancer
Phase 2 / Phase 3Not yet recruitingAssistance Publique - Hôpitaux de Paris5262025-09-012025-05-31
Domvanalimab and Zimberelimab in Advanced Liver Cancers
Zimberelimab, Domvanalimab - Hepatobiliary Cancer, Liver Cancer
Phase 2Active not recruitingUniversity of Texas Southwestern Medical Center582023-06-122026-07-02

Narrower conditions

Carcinoma, Hepatocellular (2)  ·  Cholangiocarcinoma (1)  ·  Gallbladder Neoplasms (1)  ·  Liver Neoplasms (1)  ·  Pancreatic Neoplasms (1)

Broader conditions

Adenocarcinoma (2)  ·  Carcinoma (2)  ·  Digestive System Diseases (2)  ·  Digestive System Neoplasms (2)  ·  Liver Diseases (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms by Site (2)  ·  Neoplasms, Glandular and Epithelial (2)  ·  Biliary Tract Diseases (1)  ·  Biliary Tract Neoplasms (1)  ·  Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Gallbladder Diseases (1)  ·  Liver Neoplasms (1)

Interventions

Geriatric Assessment (1)  ·  zimberelimab (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  University of Texas Southwestern Medical Center (1)

Countries

France (1)  ·  United States (1)

Top investigators

David Hsieh, MD (1)

Results publications

PMID 40592848, PMID 42481461